News

Search for Articles
Sep 27, 2022
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision...

Read More
Sep 20, 2022
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

CRANBURY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology...

Read More
Sep 19, 2022
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device

September 19, 2022 —  A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has demonstrated...

Read More
Sep 16, 2022
HAYA Therapeutics Appoints Brian C. Thomas, Ph.D., as Chairperson of the Board of Directors

LAUSANNE, Switzerland and SAN DIEGO – Sept. 15, 2022 -- HAYA Therapeutics, SA, a company...

Read More
Sep 20, 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results

MIAMI, Sept. 13, 2022 /PRNewswire/ -- RapidPulse, Inc., a privately-held medical device company developing a...

Read More
Aug 22, 2022
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision...

Read More
567891011